Serum anti-flagellin and anti-lipopolysaccharide immunoglobulins as predictors of linear growth faltering in Pakistani infants at risk for environmental enteric dysfunction by Syed, Sana et al.
eCommons@AKU
Department of Paediatrics and Child Health Division of Woman and Child Health
March 2018
Serum anti-flagellin and anti-lipopolysaccharide
immunoglobulins as predictors of linear growth
faltering in Pakistani infants at risk for
environmental enteric dysfunction
Sana Syed
Aga Khan University, sana.syed@aku.edu
Najeeha Talat Iqbal
Aga Khan University, najeeha.iqbal@aku.edu
Kamran Sadiq




See next page for additional authors
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_women_childhealth_paediatr
Part of the Pediatrics Commons
Recommended Citation
Syed, S., Iqbal, N., Sadiq, K., Ma, J. Z., Akhund, T., Qureshi, S., Gosselin, K., Gewirtz, A., Duggan, C. P., Ali, S. (2018). Serum anti-
flagellin and anti-lipopolysaccharide immunoglobulins as predictors of linear growth faltering in Pakistani infants at risk for
environmental enteric dysfunction. PLoS ONE, 13(3), e0193768.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/384
Authors
Sana Syed, Najeeha Talat Iqbal, Kamran Sadiq, Jennie Z. Ma, Tauseef Akhund, Shahida Qureshi, Kerri
Gosselin, Andrew Gewirtz, Christopher P. Duggan, and Syed Asad Ali
This article is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/384
RESEARCH ARTICLE
Serum anti-flagellin and anti-
lipopolysaccharide immunoglobulins as
predictors of linear growth faltering in
Pakistani infants at risk for environmental
enteric dysfunction
Sana Syed1,2,3, Najeeha T. Iqbal2, Kamran Sadiq2, Jennie Z. Ma4, Tauseef Akhund2,
Wenjun Xin4, Sean R. Moore1, Enju Liu3, Shahida Qureshi2, Kerri Gosselin3,
Andrew Gewirtz5, Christopher P. Duggan3,6,7, S. Asad Ali2*
1 Department of Pediatrics, University of Virginia, Charlottesville, VA, United States of America,
2 Department of Pediatrics, the Aga Khan University, Karachi, Pakistan, 3 Division of Gastroenterology,
Hepatology and Nutrition, Boston Children’s Hospital, Boston, MA, United States of America, 4 Department
of Public Health Sciences, University of Virginia, Charlottesville, VA, United States of America, 5 Center for
Inflammation Immunity & Infection, Georgia State University, Atlanta, GA, United States of America,
6 Departments of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA,





Environmental Enteric Dysfunction (EED) in children from low-income countries has been
linked to linear growth declines. There is a critical need to identify sensitive and early EED
biomarkers.
Objective
Determine whether levels of antibodies against bacterial components flagellin (flic) and lipo-
polysaccharide (LPS) predict poor growth.
Design/Methods
In a prospective birth cohort of 380 children in rural Pakistan blood and stool samples were
obtained at ages 6 and 9 months. Linear mixed effects models were used to examine longitudi-
nal associations between quartiles of anti-flic and anti-LPS antibodies and changes in LAZ,
WAZ and WLZ scores. Spearman’s correlations were measured between anti-flic and anti-LPS
immunoglobulins with measures of systemic/enteric inflammation and intestinal regeneration.
Results
Anti-LPS IgA correlated significantly with CRP, AGP and Reg1 serum at 6mo and with MPO
at 9mo. In multivariate analysis at 6mo of age, higher anti-LPS IgA levels predicted greater
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declines in LAZ scores over subsequent 18mo (comparing highest to lowest quartile, β (SE)
change in LAZ score/year = -0.313 (0.125), p-value = 0.013). Anti-flic Ig A in the two highest
quartiles measured at 9mo of age had declines in LAZ of -0.269 (0.126), p = 0.033; and
-0.306 (0.129), p = 0.018 respectively, during the subsequent 18mo of life, compared to
those in the lowest quartile of anti-flic IgA.
Conclusions and relevance
Elevated anti-flic IgA and anti-LPS IgA antibodies at 6 and 9mo, predict declines in linear
growth. Systemic and enteric inflammation correlated with anti-LPS IgA provides mechanis-
tic considerations for potential future interventions.
Introduction
Approximately 3 million children under the age of 5 years die annually due to malnutrition[1],
and each year about 525,000 children under 5 die due to diarrhea globally[2]. Evidence has
arisen from clinical and animal model studies of undernutrition and diarrhea to support a
reciprocal, additive relationship of recurrent enteric infections, along with subclinical infec-
tions and malnutrition with resultant environmental enteric dysfunction (EED). EED is a sub-
clinical condition of the small intestine characterized by villous atrophy, crypt hyperplasia,
increased intestinal permeability, inflammatory cell infiltration, and malabsorption [3–5].
EED is hypothesized to be mediated by aberrant innate and adaptive host immune responses
in the context of chronic mucosal inflammation directed at a normal or possibly abnormal
enteric microbiome [4,6].
In other chronic enteric inflammatory disease states such as inflammatory bowel disease
(IBD), bacterial flagellin has been proposed to be involved in triggering an altered adaptive
response by the mucosal immune system. Flagellin is the monomeric subunit that comprises
bacterial flagella and is therefore expressed abundantly by motile gut bacteria [7]. The presence
of flagellin on the luminal side of intestinal epithelial cells does not trigger inflammation; how-
ever, flagellin binds Toll-like receptor 5 (TLR5) found predominantly on the basolateral side of
these cells, triggering an intense inflammatory response [8, 9, 10, 11]. This may occur during
situations when the intestinal cell or mucosal barrier is breached, either by 1) translocation of
flagellin across the epithelial cell monolayer as occurs with the pathogen Salmonella enterica
serovar Typhimurium [9] or 2) mucosal injury that exposes the intestinal basolateral mem-
brane to the hostile environment of the gut luminal contents. The resulting inflammatory
response forms a major line of innate immune defense against bacterial infection, but such a
response could also be a contributory factor to the pathogenesis of EED. Thus the goal of this
work was to determine if flagellin-specific (flic) immunoglobulins, which would indicate that
sufficient flagellin had penetrated the gut and triggered the innate immune system, are associ-
ated with growth faltering due to EED. Flagellin monomers purified from a human commensal
Escherichia coli strain (F-18) serve as a “generic” flagellin, antibodies to which cannot distin-
guish between bacterial species and serotypes [12,13]. Levels of IgG and IgA that recognized
bacterial lipopolysaccharide (LPS) were also measured because some studies have observed
these immunoglobulins to be elevated in IBD [14].
Therefore, the aims of this paper were to: 1) Determine whether levels of flic- and LPS-spe-
cific IgA and IgG were associated with changes in growth as measured by Z scores of weight-
for-height (WLZ), weight-for-age (WAZ), and height-for-age (LAZ). 2) Explore the associations
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of flic- and LPS-specific IgA and IgG at 6 and 9 months with biomarkers of systemic/enteric
inflammation and intestinal regeneration (C-reactive protein (CRP), alpha- 1-acid glycoprotein
(AGP), ferritin, myeloperoxidase (MPO), neopterin (NEO), regenerating gene 1β (Reg1b) stool
and serum) in a cohort of infants at risk for growth faltering. We hypothesized that higher levels
of a mucosal inflammatory response (i.e. as assessed by plasma flic- and LPS-specific IgA and
IgG) would be associated with decreased LAZ, WAZ, and WLZ scores.
Methods
Study design and participants
Subjects included in this analysis were part of a prospective community-based active surveil-
lance birth cohort with an intervention arm that was designed to investigate various biomark-
ers of growth faltering, response to Ready-to-Use-Therapeutic-Food (RUTF) and endoscopic
evaluation of children with an inadequate growth response to RUTF (S1 Fig) [15,16]. The
study site was in the rural district of Matiari, located in the province of Sindh about 200 km
(124 miles) north of Karachi, Pakistan. The Department of Paediatrics and Child Health at
Aga Khan University (AKU), Pakistan has established research infrastructure and relation-
ships in this area in collaboration with the Government of Pakistan since 2002 for the purpose
of community-based research.
Enrollment and assessment of newborns was done during routine surveillance of pregnant
women of reproductive age (13–49 years) by community health workers. At the time of the
first study visit, mothers were asked to approximate the duration of pregnancy and this was
used to calculate birth gestational age of the infants. We have added this as a recall bias to our
limitation. Study inclusion criteria were: 1) newborns aged up to 14 days; 2) absence of any
major congenital abnormalities and; 3) ability to obtain informed consent from parents or
guardians. Infants of families planning to move out of the study area within 6 months of birth
were excluded from the trial. Enrolled children were followed from birth (0 to 14 days) until
18 months of age with weekly home visits during the study period from October 2012 to
November 2015. All families enrolled in the study were provided with cell phone contact infor-
mation of key study physicians to enable direct and immediate contact in the case of any
urgent medical need by the study participants. Monthly measurements were recorded by
trained community health workers using standard techniques: child’s weight using a digital
infant balance with 20-g precision (TANITA 1584) and measured the child’s length with 1 mm
precision (using a rigid length board with a movable foot piece). Standardization of measure-
ments was ensured through regular staff training and cross checks.
For purposes of comparison, anti-flic and anti-LPS antibodies were also measured in a
cohort of 36 healthy infants seen at Boston Children’s Hospital. After institutional review
board approval was obtained, any infant from birth to 12 months of age with an excess blood
sample in the Boston Children’s Hospital central laboratory was eligible for inclusion. Subjects
were excluded from participation in the research study if 1) their LAZ was<-2 or >2; 2) their
WAZ was<-2 or >2; 3) no growth data were available for the review and analysis; 4) there
was evidence of a recent fever (temperature >38.5 C in the past 48 h); or 5) there was any evi-
dence of a systemic illness (e.g., malignancy). A total of 67 infants were screened for enroll-
ment, and 31 infants were excluded. The mean age of the remaining 36 infants at the time of
the blood draw was 9.5 months (range: 5–12 months).
Biological specimen collection and measurement of biomarkers
Blood was obtained from enrolled children in Pakistan at 6 and 9 months of age. S1 Table
summarizes the rationale and purpose behind their measurements in our study.
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Blood samples were centrifuged and plasma removed within 2 h of blood collection in the
field site research laboratory. Samples were transported at 4˚C from Matiari to the AKU Infec-
tious Disease Research Lab (IDRL) under cold chain maintenance. Aliquots were stored in
-80˚C freezers with an automatic backup electricity generator. Peripheral blood samples taken
at 6 and 9 months were tested for flic- and LPS-specific IgA and IgG concentrations measured
by ELISA, as previously reported [17]. Microtiter plates were coated with purified E. coli flagel-
lin (100ng/well) or purified E. coli LPS (2 μg/well). Serum samples from study participants
were diluted 1:200 and applied to wells coated with flagellin or LPS. After incubation and
washing, the wells were incubated with anti-human IgA (KPL) or IgG (GE Healthcare) cou-
pled to horseradish peroxidase. Quantification of total immunoglobulins was performed using
the colorimetric peroxidase substrate tetramethylbenzidine, and optical density (OD) was read
at 450 nm with an ELISA plate reader. Data are reported as OD corrected by subtracting back-
ground levels, which were determined by readings in samples lacking serum. Commercial
ELISA kits for the estimation of regenerating gene 1β (Reg1) (TechLab, Blacksburg, Virginia)
in stool and serum. For intestinal inflammation, commercial ELISA kits for the estimation of
myeloperoxidase (MPO) (Immunodiagnostic AG, Stubenwald-Allee, Bensheim) and neop-
terin (NEO) (GenWay Biotech, San Diego, CA) in stool samples were used as reported previ-
ously [18]. Biomarkers of systemic inflammation and C-reactive protein (CRP) and alpha-
1-acid glycoprotein (AGP) and ferritin were analyzed on Hitachi 902 analyzer (Roche Diag-
nostics, Holliston, MA). All protocols were followed as per manufacturers’ instructions. The
final dilution for serum and stool biomarkers was determined by selecting the most appropri-
ate concentration of a biomarker falling in the linear range of standard curve. Reg1B was per-
formed in two dilutions of 1:40,000 and 1:100,000, NEO at the dilution of 1:250 and MPO at
1:500. All plates were read on Biorad iMark (Hercules, CA) plate reader.
Statistical analysis
We used the WHO Child Growth Standards (WHO Anthro, Geneva, Switzerland) [19] to cal-
culate z-scores, and assessed growth both as continuous measures of length-for-age z-score
(LAZ), weight-for-age z-score (WAZ) and weight-for-length z-score (WLZ); and as catego-
rized variables of stunting as LAZ < −2 SD (standard deviation), underweight as WAZ < −2
SD and wasting as WLZ < −2 SD. In accordance with WHO recommendations, we set all
extreme LAZ (<-6 or >6), WLZ (<-5 or >5), and WAZ (<-6 or >5) values to missing as rec-
ommended [20]. Participant descriptive statistics were presented as means (standard error,
SE) and as percentage (95% confidence interval, CI) for continuous and categorical outcomes.
Due to the skewed distributions of most biomarkers, Spearman correlations were estimated
between flic- and LPS-specific IgA and IgA at 6 and 9 months with biomarkers of systemic
and enteric inflammation and intestinal regeneration (CRP, AGP, ferritin, MPO, NEO, Reg1b
stool and serum) along with associated 95% confidence intervals.
Monthly Z-scores (LAZ/WAZ/WLZ) from birth to 18 months were modeled as the longitu-
dinal growth responses in a linear mixed effects model using the following equation for the ith
child at the jth time tij with the biomarker value (biomarkeri):
LAZij ¼ ðb0 þ a0iÞ þ b1 biomarkeri þ ðb2 þ a2iÞ tij þ b3 biomarkeri  tij þ εij;
where βs are the fixed effects, αs are the random effects, and ε is the error term. Random inter-
cept and random slope were specified in the model to allow subject-specific variation in the
growth. An individual biomarker was considered as a fixed effect, and its association with the
growth was characterized by its interaction with time. That is, the biomarker effect on the
growth was quantified by its influence on the growth slope, the rate of growth change per year.
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Due to their skewed distributions, biomarkers were divided into four quartiles as q1 (0-
25th percentile), q2 (25th -50th percentile), q3 (50th- 75th percentile) and q4 (75th -100th per-
centile) at 6 and 9 months, and were considered categorical predictors. The lowest quartile
(q1) was used as the reference group. To assess the association between each biomarker and
the anthropometric outcomes, we first performed a series of univariate analyses, and then fol-
lowed by multivariable analyses that adjusted for potential confounders including child sex,
preterm birth, maternal age, maternal literacy, antibiotic use at baseline (6 or 9 months of age)
and whether RUTF was received or not. Additional models were also computed using all four
biomarkers as continuous variables instead of quartiled predictors. These covariates were
selected based on their P value<0.10 in univariate analysis or traditionally considered as a risk
factor for the child growth outcomes in literature, or biological pathway plausibility informed
by a hypothesized conceptual causal diagram (S2 Fig) for determinants of EED.
Growth was also modeled as time-to-event outcomes in Cox proportional hazards models
to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for stunt-
ing, wasting and underweight across the quartiles of the each biomarker. Each growth out-
come was modeled separately and the first time the child reached a score of< -2 SD signified
an “event”. Children who did not develop the “event” were censored at the time of last anthro-
pometric assessment. By design in our birth cohort, we had included children who were
stunted/wasted or underweight at birth for this analysis but excluded those who already experi-
enced the event of interest at baseline. E.g., for our stunting analysis we excluded children who
were already stunted between age 0 to 6 months, with similar exclusions made for each of our
wasting and underweight analysis. Similar to the linear mixed effects modeling, we first per-
formed a series of univariate Cox regression and then multivariable analyses adjusting the
same set of covariates. P-value for trend was calculated by including the median value within
each quartile as a continuous term in the regression model. All analyses were performed using
SAS version 9.4 (SAS Institute, Cary, NC, USA). Descriptive figures were made using Graph-
Pad Prism version 6.00 for Windows and GraphPad Software (La Jolla California USA, www.
graphpad.com).
Ethics Statement and Study Data. Institutional approval was granted by the Aga Khan Uni-
versity Ethical Review Committee, Harvard T.H. Chan School of Public Health Human Sub-
jects Committee, the Boston Children’s Hospital Institutional Review board, and the
University of Virginia Institutional Review Board. All parents provided written informed
consent.
Results
Summary statistics of variables from the cohort which were included in the multivariable lin-
ear mixed effects models at 6 and 9 months are shown in Table 1.
Maternal demographics were notable for high illiteracy (87% at both 6 and 9 months).
Almost all infants were still breastfeeding at both time points (>97% at both 6 and 9 months).
Cohort characteristics were notable for having equal gender distribution among infants, more
than half born preterm (<37 weeks) and about one third having low birth weight. Median (q1,
q3) LAZ, WAZ, and WLZ scores (Fig 1) trended downwards over 18 months of follow-up.
Fig 2 illustrates the progressive increase in the concentrations of all four immunoglobulins
over the follow-up period. Mean concentrations of both anti-flic IgA and anti-LPS IgA were
significantly higher in the healthy Boston children than in the Pakistani children at both 6 and
9 months of age, whereas mean concentrations of anti-flic IgG were significantly higher in the
Pakistani infants compared with healthy controls at both 6 and 9 months of age. Only anti-LPS
IgG at 9 months of age was significantly higher in the Pakistani infants.
Associations of flagellin and lipopolysaccharide immunoglobulins with environmental enteric dysfunction
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The interrelationships of all four immunoglobulins of bacterial translocation both with
measures of systemic/enteric inflammation and intestinal regeneration (CRP, AGP, ferritin,
MPO, NEO, Reg1b in stool and serum) and within themselves were measured using the Spear-
man correlation coefficients as summarized in Table 2 and S2 Table.
We found that at 6 months anti-LPS IgA and IgG were significantly correlated with mea-
sures of systemic inflammation (r = 0.12, 0.18 for CRP and AGP; ρs = 0.12 for AGP respec-
tively). At 9 months anti-LPS IgA was significantly correlated with enteric inflammation (ρs =
0.11 with MPO) but interestingly, there was significant negative correlation of anti-LPS IgG
with NEO, ρs = -0.17. Anti-flic IgA and IgG significantly correlated with systemic inflamma-
tion (ρs = 0.15 with AGP and ρs = 0.16 with ferritin respectively) at 9 months with anti-flic IgG
also correlating significantly with enteric inflammation (NEO, ρs = -0.18); this too was a nega-
tive relationship, however. Anti-Flic IgA was highly correlated with the other three immuno-
globulins at 6 and 9 months, ρs = 0.57, 0.63 and 0.40 at 6 months and ρs = 0.56, 0.82, and 0.31
at 9 months with anti-Flic IgG, anti-LPS IgA, and anti-LPS IgG, respectively; p<0.001. With
the exception of anti-Flic IgG, the remaining three immunoglobulins at 6 months were all sig-
nificantly correlated with their 9 month levels.
In the linear mixed effects models (Table 3, and S3 and S4 Tables), we analyzed the as-
sociation of each of our four immunoglobulins with the longitudinal anthropometric data.
At 6 months of age, the highest quartile of anti-LPS IgA was associated with β (SE) change in
LAZ of -0.33 (0.12) per year, compared to the lowest quartile of anti-LPS IgA (<0.17 OD)
(p-value = 0.008). At 9 months of age, the two highest quartiles of anti-flic IgA were associated
with β (SE) change per year in LAZ of -0.29 (0.13), p-value = 0.02; and -0.32 (0.13), p-value =
0.01 respectively, during the first 18 months of life, compared to the lowest quartile of anti-flic
IgA. At 6 months of age, the second quartile of anti-LPS IgA was associated with β (SE) change
per year in WLZ of 0.34 (0.15), p-value = 0.03, during the first 18 months of life, compared to
the lowest quartile of anti-flic IgA. In our sub-analyses using the Cox proportional hazards
models with immunoglobulins at 6 months of age (S5 Table), those in the second (HR 1.57,
95%CI: 0.81, 3.05) and third quartile (HR 2.23, 95%CI: 1.15, 4.33) had an increased risk of
Table 1. Infant and Maternal Characteristics at six and nine months.
N (%) or Median (q1,q3)
Maternal Baseline Characteristics 6 months 9 months
Maternal Literacy, no 310 (87.3%) 273 (87.5%)
Maternal Age, <30 y 158 (44.3%) 135 (43.1%)
Antenatal care received, yes 249 (68.0%) 209 (66.6%)
Breastfeeding, yes 361 (99.2%) 305 (97.4%)
Child Baseline Characteristics
Male 184 (51.4%) 159 (50.8%)
Low birth weight, <2500g 129 (35.3%) 111 (35.4%)
Born preterm, <37 weeks 232 (64.8%) 201 (64.2%)
Length-for-age Z-score -2.0 (-2.9, -1.3) -2.2 (-2.8, -1.4)
Weight-for-length Z-score -0.7 (-1.4, 0.2) -0.8 (-1.6, 0.2)
Weight-for-age Z-score -1.9 (-2.8, -1.1) -1.9 (-2.8, -1.1)
Antibiotic use at the time of biomarker measurement, yes 41 (11.6%) 38 (12.4%)
Note: n = 376 at six month and n = 322 at nine month
Summary statistics presented of variables included in the multivariable linear mixed effects models at six and nine
months.
https://doi.org/10.1371/journal.pone.0193768.t001
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Fig 1. Median LAZ, WLZ and WAZ scores in Pakistani infants over 18 months of follow-up. Dashed lines show q1 and q3 quartiles.
Abbreviations: LAZ = Length-for-Age Z score, WLZ = Weight-for-Length Z score and WAZ = Weight-for-Age Z score.
https://doi.org/10.1371/journal.pone.0193768.g001
Fig 2. Anti-Flagellin and anti-LPS immunoglobulin concentrations in Pakistani infants. Closed shapes indicate
means±SDs in Pakistani infants over the follow-up period. Open shapes indicate means±SDs values in 36 healthy
Boston infants with a mean age of 9.5 months. n = 380 for all immunoglobulins in Pakistani infants at 6 and 9 months
of age; n = 36 for all immunoglobulins in Boston infants at 9.5 months of age.  p< 0.0001,  p< 0.01 and  p<
0.05 for comparisons of mean biomarker concentrations in Pakistani infants with those of healthy Boston infants
(unpaired t tests).
https://doi.org/10.1371/journal.pone.0193768.g002
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stunting, however this increased risk was not sustained in the highest quartile (HR 0.96, 95%
CI: 0.48, 1.91, P-trend = 0.89) when compared to children in first quartile of anti-LPS IgA
level. Lastly, in multivariable linear mixed effects models (S6 Table) we analyzed the associa-
tion of each of our four biomarkers of EED as continuous variables with the longitudinal
anthropometric data. The only significant result of note was at 9 months of age, anti-Flic IgG
was associated with β (SE) change in LAZ of -0.30 (0.15) per year (p-value = 0.05).
Discussion
The present study reports associations of flic- and LPS- specific immunoglobulins, which are
biomarkers of bacterial translocation, and growth faltering in 380 Pakistani children at risk of
EED. Notable findings included: (1) while we observed a clear trend of increasing anti-LPS and
anti-flic IgA and IgG concentrations over the first year of life, anti-flic and anti-LPS IgA were
both lower than in our Boston controls; (2) anti-LPS IgA correlated significantly with serum
CRP, AGP and Reg1 at 6 months and with fecal MPO at 9 months; (3) high anti-LPS IgA levels
at 6 months of age and higher anti-flic IgA levels at 9 months of age were associated with a trend
to greater decrease in LAZ scores over 18 months; (4) Compared to children in first quartile of
anti-LPS IgA level, those in the second and third quartile had an increased risk of stunting.
A longitudinal study studying the growth of 590 Tanzanian infants and the relationship of
these same flic- and LPS-specific immunoglobulins was recently published but with contrast-
ing results [21]. While in both studies, anti-LPS and anti-flic IgA and IgG concentrations
increased over the first year of life, Tanzanian children had significantly higher antibody (both
IgA and IgG) concentrations compared with healthy Boston controls, whereas in the Pakistani
cohort the IgA to Flic and LPS was lower at both 6 and 9 mo when compared to the Boston
controls. In Tanzania, infants at 6 weeks of age in the highest quartile of all the EED antibody
concentrations were approximately twice as likely to develop underweight (WAZ<-2) after
Table 2. Correlation coefficient matrix of immunoglobulins to flagellin and lipolysaccharide with measures of systemic inflammation and enteric inflammation &
regeneration.
At 6 months At 9 months















































At 6 months At 9 months
Anti-Flic IgA,
OD
0.02 0.11 0.02 -0.03 0.06 0.002 0.21 0.01 0.15 0.04 0.07 -0.10 0.04 0.04
Anti-Flic IgG,
OD
0.04 0.06 0.02 0.01 0.02 0.02 0.10 0.01 0.07 0.16 0.07 -0.18 0.11 0.05
Anti-LPS IgA,
OD
0.12 0.18 0.06 -0.04 -0.03 0.04 0.20 0.05 0.11 0.03 0.11 -0.10 0.07 0.02
Anti-LPS IgG,
OD
0.10 0.12 0.03 -0.02 -0.03 -0.03 0.08 0.02 -0.005 0.10 0.03 -0.17 0.10 -0.04




Abbreviations: Flagellin = Flic; Immunoglobulin = Ig; Lipopolysacccharide = LPS; alpha glycoprotein = AGP; C-reactive protein = CRP; Myeloperoxidase = MPO;
Neopterin = NEO; regenerating gene 1β = REG1b
https://doi.org/10.1371/journal.pone.0193768.t002
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adjustment for covariates (P-trend < 0.05) than were infants with Ig concentrations in the
lowest quartile. Children with increased concentrations of anti-flic IgA were also more likely
to become wasted (WHZ<-2); however, there was no association between any of the markers
and subsequent stunting. In Pakistan, infants at 6 months of age with anti-LPS IgA in the high-
est quartile had significant decreases in vertical growth as measured by β (SE) change in LAZ
of -0.313 (0.125) per year (p-value = 0.013). Using stunting as our outcome, we showed that
children with higher anti-LPS IgA levels (in the second (HR 1.57, 95%CI: 0.81, 3.05) and third
quartile (HR 2.23, 95%CI: 1.15, 4.33)) were approximately twice as likely to develop stunting,
after adjustment for covariates, than were infants with Ig concentrations in the lowest quartile.
Pakistani infants at 9 months of age with anti-flic IgA in the two highest quartiles of anti-flic
IgA were similarly associated with significant decreases in vertical growth as indicated by β
(SE) change per year in LAZ of -0.269 (0.126), p-value = 0.033; and -0.306 (0.129), p-value =
0.018 respectively, during the first 18 months of life, compared to the lowest quartile of anti-
flic IgA. This was also true of infant with higher anti-LPS IgA levels (β (SE) change in LAZ of
-0.255 (0.127) per year during the first 18 months of life, compared to the lowest quartile of
anti-LPS IgA (p-value = 0.045)). Neither the Tanzanian study nor ours measured total IgA;
therefore we are unable to determine if the difference in comparison with the same Boston
controls was due to an underlying IgA deficiency in our Pakistani cohort. Given that IgA defi-
ciency varies in prevalence depending on ethnic background [22], such an analysis would be
Table 3. The association of anti-flagellin and anti-lipopolysaccharide immunoglobulin concentrations at 6 and 9 months with annual Z score changes for length
using linear mixed effects models.
Immunoglobulins at 6 months with annual ΔLAZ as outcome Immunoglobulins at 9 months with annual ΔLAZ as outcome
unadj β (SE) p-value adj β (SE)1 p-value unadj β (SE) p-value adj β (SE)1 p-value
Flic IgA, OD Flic IgA, OD
Q1 <0.21 ref — ref — Q1 <0.32 ref — ref —
Q2 0.21 to <0.30 0.29(0.12) 0.02 0.21(0.12) 0.09 Q2 0.32 to <0.44 -0.22(0.13) 0.09 -0.22(0.13) 0.08
Q3 0.30 to <0.42 0.08(0.12) 0.52 0.05(0.12) 0.67 Q3 0.44 to <0.61 -0.25(0.13) 0.049 -0.29(0.13) 0.02
Q4 >0.42 -0.05(0.12) 0.68 -0.04(0.12) 0.72 Q4 >0.61 -0.30(0.13) 0.03 -0.32(0.13) 0.01
Flic IgG, OD Flic IgG, OD
Q1 <0.47 Ref — Ref — Q1 <0.65 Ref — Ref —
Q2 0.47 to <0.60 0.03(0.13) 0.82 0.11(0.12) 0.39 Q2 0.65 to <0.82 -0.06(0.13) 0.63 -0.04(0.13) 0.73
Q3 0.60 to <0.75 0.10(0.12) 0.44 0.12(0.12) 0.33 Q3 0.82 to <1.03 -0.04(0.13) 0.78 -0.07(0.13) 0.59
Q4 >0.75 -0.14(0.12) 0.26 -0.10(0.12) 0.41 Q4 >1.03 -0.27(0.13) 0.04 -0.23(0.13) 0.07
LPS IgA, OD LPS IgA, OD
Q1 <0.17 Ref — Ref — Q1 <0.23 Ref — Ref —
Q2 0.17 to <0.24 0.01(0.12) 0.91 -0.08(0.12) 0.51 Q2 0.23 to <0.36 -0.18(0.13) 0.16 -0.19(0.13) 0.14
Q3 0.24 to <0.34 -0.04(0.13) 0.78 -0.09(0.12) 0.47 Q3 0.36 to <0.56 -0.27(0.13) 0.037 -0.24(0.13) 0.07
Q4 >0.34 -0.30(0.12) 0.02 -0.33(0.12) 0.008 Q4 >0.56 -0.14(0.13) 0.28 -0.18(0.13) 0.16
LPS IgG, OD LPS IgG, OD
Q1 <0.33 ref — ref — Q1 <0.44 Ref — Ref —
Q2 0.33 to <0.47 -0.07(0.12) 0.58 -0.04(0.13) 0.78 Q2 0.44 to <0.62 0.11(0.13) 0.38 0.16(0.13) 0.21
Q3 0.47 to <0.66 0.14(0.12) 0.25 0.15(0.12) 0.23 Q3 0.62 to <0.89 -0.05(0.13) 0.69 -0.05(0.13) 0.70
Q4 >0.66 -0.10(0.12) 0.40 -0.08(0.12) 0.54 Q4 >0.89 0.09(0.13) 0.48 0.06(0.13) 0.65
Note
1Adjusted for child sex (male/female), preterm birth (yes/no), maternal age (30, <30years), maternal literacy (yes/no), antibiotic use (yes/no), RUTF (yes/no).
Abbreviations: Flic = Flagellin; LPS = Lipopolysaccharide; IgA = Immunoglobulin A; IgG = Immunoglobulin G; ΔLAZ = change in Length-for-age Z scores;
RUTF = ready to use therapeutic food.
https://doi.org/10.1371/journal.pone.0193768.t003
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worth conducting in future studies. Further, the study designs of the two projects were differ-
ent. The Tanzanian study excluded subjects from participation in the research study if their
LAZ was <-2 or > 2; therefore, the Tanzanian cohort was healthier at baseline by design.
Our results are supported by a recent case-control field study in Fortaleza, Brazil investigat-
ing biomarkers of EED, where Guerrant, et al. reported that anti-flic IgA and anti-LPS IgA
(n = 292; r = 0.15, p = 0.011 and r = 0.14, p = 0.017) were significantly correlated with more
severe stunting at the time of enrollment but were not predictive of subsequent growth (out-
come defined as delta LAZ) [23]. This study however differed in design from ours in that, in
the Brazilian study, malnourished or “case” children were initially defined as having WAZ
scores<-2 and, to the extent possible, age and gender matched ‘non-malnourished controls’
were defined as having a WAZ greater than -1; biomarkers were then measured in these cases
and controls. Follow up anthropometry at 2–6 months after initial sampling was also done to
assess these biomarkers as predictors of subsequent growth. This differs from our study, in
which monthly measures of growth were made over 18 months of follow-up with biomarkers
measured at two time-points in the first year of life when presumably the effect of the environ-
ment would come into play. Despite these differences, our study and the field study conducted
by Guerrant, et al. support the role of anti-flic and anti-LPS IgA as biomarkers of EED or pre-
dictors of subsequent stunting.
Using stool enteropathogen and biomarker data from within the framework of the Etiol-
ogy, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Conse-
quences for Child Health and Development (MAL-ED) birth cohort study that included
children from eight countries, Kosek et al. recently reported associations between entero-
pathogens and linear growth mediated through systemic inflammation[24]. At age group
4–11 months, fecal MPO was negatively associated with sample Z-scores of lactulose:man-
nitol (L:M) assays (assessing intestinal permeability) while in children aged 12–21 months
MPO concentration was positively associated with AGP, while NEO was negatively associ-
ated with AGP. In contrast to this, we found early positive associations at six months of
measures of intestinal permeability/ bacterial translocation (anti-LPS IgA and IgG) with
CRP and AGP with anti-LPS IgA significantly and positively correlating with MPO. Similar
to Kosek et al., we found significant negative correlation of our measures of intestinal per-
meability/ bacterial translocation (anti-LPS IgG) with NEO, ρs = -0.17. Of note, in a sepa-
rate analysis studying the effect of biomarkers of systemic inflammation (CRP, Ferritin,
AGP) and enteric inflammation (MPO, Neopterin) on growth, we found that high levels of
ferritin, CRP and AGP were significantly associated with decreased annual LAZ scores [16].
In this parent analysis, we also found that MPO is tightly correlated with both CRP (both 6
and 9 months) and AGP (at 6 months only) with NEO not correlating with MPO at any
time point and only with ferritin at 9 months.
There are several strengths of our study which merit mention. We followed a large cohort
of children closely over an 18mo period of follow-up, a challenging feat in a population which
was geographically spread out with poor routes of transportation. Our monthly repeated mea-
sures of growth (length and weight) along with our mixed methods modeling (using time vary-
ing variables) allowed our analysis to take into consideration that normal human growth is
pulsatile with intervals of rapid growth which are separated by periods of no measurable
growth [25]. We measured serum immunoglobulins at two time points in the first year of life
(6 and 9 months of age) and we included multiple potentially confounding factors in our mul-
tivariable models. Lastly, we evaluated growth faltering as changes in linear slope of z scores
for length/weight/weight for length while additionally categorizing growth into stunting, wast-
ing and underweight. We were limited in that we used growth faltering during the first 18
months of life as a clinical substitute of EED and that we did not gather dietary intake data.
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Furthermore, the Boston control group was small, from a much broader range of ages, includ-
ing much older children, all of which were grouped together rather than trying to perform any
form of age-matching. We were also limited by maternal recall bias in how birth gestational
age of the study infants was estimated. Ideally, we would have been able to confirm presence of
EED using gold standards such as intestinal biopsies or L:M differential absorption ratios, but
the scarcity of these data made such an analysis challenging.
In summary, serum levels of both anti-LPS and anti-flic IgA and IgG concentrations increased
over the first year of life. Higher levels of both flic- and LPS-specific IgA were associated with lin-
ear faltering over the first 18 months of life. Children with higher anti-LPS IgA levels had an
increased risk of stunting. Future directions could include the evaluation of serum IgA to stool
ratios as a markers of alterations in the intestinal microbial communities and mucosal immunity
in malnourished children. Further studies relating these biomarkers to EE small bowel histology
would help shed further light on the alterations in the intestinal immune response.
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